Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in Myasthenia Gravis
NCT00285350Phase 3Completed
- Sponsor
- Food and Drug Administration
- Start
- Sep 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mycophenolate mofetil in myasthenia gravis (MG), sponsored by Food and Drug Administration. Started Sep 2002; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT00285350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285350.